-
F182541-250mgFmoc-asp(2-phenylisopropyl ester)-oh
-
F182541-5gFmoc-asp(2-phenylisopropyl ester)-oh
-
N349902-100mgFmoc-Asp(EDANS)-OH
-
N349902-1gFmoc-Asp(EDANS)-OH
-
N349902-250mgFmoc-Asp(EDANS)-OH
-
A107817-10gFmoc-Asp(OAll)-OH.
-
A107817-1gFmoc-Asp(OAll)-OH.
-
A107817-25gFmoc-Asp(OAll)-OH.
-
A107817-5gFmoc-Asp(OAll)-OH.
-
F481462-1gDescriptionAn excellent derivative for minimizing aspartimide formation during Fmoc SPPS, including those containing the Asp-Gly sequence. The bulky OBne protecting group offers considerably more protection against the formation of
-
F481462-5gDescriptionAn excellent derivative for minimizing aspartimide formation during Fmoc SPPS, including those containing the Asp-Gly sequence. The bulky OBne protecting group offers considerably more protection against the formation of
-
F481465-1gDescriptionAn excellent derivative for minimizing aspartimide formation during Fmoc SPPS of Asp-containing peptides. The bulky OEpe protecting group offers considerably more protection against the formation of aspartimide-related by-products than